DA90 - Non-Structural Anomalies of Small Intestine Development: Complete Coding Guide

1. Introduction

Non-structural anomalies of small intestine development represent a heterogeneous group of congenital defects that affect the proper formation, growth, and differentiation of the small intestine during the fetal period. Unlike evident structural malformations, these anomalies involve functional, metabolic, or cellular maturation alterations that may not be immediately apparent at birth but significantly compromise intestinal function.

These conditions arise from interference in the complex processes of intestinal embryogenesis, which occur mainly between the fourth and twelfth week of gestation. Causative factors include specific genetic mutations, chromosomal aberrations, exposure to teratogenic agents, maternal nutritional deficiencies, and other environmental factors that can alter normal cellular development without necessarily causing gross anatomical malformations.

The clinical importance of these anomalies lies in their capacity to cause malabsorption, food intolerances, failure to thrive, and severe nutritional complications. Although less frequent than other pediatric gastrointestinal conditions, their impact on quality of life and child development is considerable. Early diagnosis and appropriate coding are fundamental to ensure proper management, allow accurate epidemiological studies, and ensure access to necessary therapeutic resources.

Correct coding with code DA90 is critical to differentiate these conditions from other intestinal pathologies, allowing adequate resource allocation, planning of specialized care, and appropriate longitudinal follow-up of these patients throughout their development.

2. Correct ICD-11 Code

Code: DA90

Description: Non-structural anomalies of small intestine development

Parent category: Diseases of the small intestine

Official definition: Any congenital defect of the small intestine resulting from interference with normal fetal growth and differentiation. Such defects may arise at any stage of embryonic development, vary greatly in type and severity, and are caused by a wide variety of determining factors, including genetic mutations, chromosomal aberrations, teratogenic agents, and environmental factors. Most developmental defects are apparent at birth, especially any structural malformation, but some become evident later.

This specific ICD-11 code was created to capture anomalies that do not manifest primarily as macroscopic structural alterations, but rather as dysfunctions in cellular development, enzymatic maturation, or tissue differentiation of the small intestine. The classification recognizes that not all congenital anomalies present visible anatomical deformities, but may have significant functional impact.

Code DA90 belongs to the chapter on diseases of the digestive system and is part of a hierarchical structure that allows increasing specificity in clinical documentation. Its proper use facilitates communication among healthcare professionals, improves the accuracy of medical records, and contributes to global epidemiological research on these rare conditions.

3. When to Use This Code

The code DA90 should be applied in specific clinical situations where there is clear evidence of congenital anomaly of the small intestine without gross structural malformation. Below are detailed practical scenarios:

Scenario 1: Congenital Disaccharidase Deficiency A two-month-old infant presents with persistent watery diarrhea, abdominal distension, and failure to gain weight since the introduction of milk formula. Investigation reveals primary lactase deficiency of congenital origin, confirmed by intestinal biopsy showing reduced enzymatic activity in intestinal epithelial cells, without mucosal structural alterations. This is a classic example of non-structural anomaly of intestinal development.

Scenario 2: Congenital Enteropathy with Villous Atrophy A newborn develops severe diarrhea and dehydration in the first weeks of life, independent of the type of feeding. Duodenal biopsy demonstrates villous atrophy of genetic basis (non-celiac), with defect in enterocyte differentiation. Genetic studies confirm mutation in genes related to intestinal epithelial development, without obstruction or anatomical malformation.

Scenario 3: Congenital Hypoplasia of Enteroendocrine Cells A child with history of malabsorption since birth, presenting with abnormally low levels of intestinal hormones. Histological investigation reveals reduced number of enteroendocrine cells in the small intestine due to defect in embryonic development, affecting the regulation of motility and digestive secretion, but without alterations in intestinal architecture.

Scenario 4: Congenital Intestinal Epithelial Dysplasia An infant with intractable diarrhea since the neonatal period, requiring prolonged parenteral nutrition. Intestinal biopsy shows dysplasia of the intestinal epithelium with abnormal cell differentiation, but without stenosis, atresia, or other structural malformations. Molecular analysis identifies mutation in genes responsible for intestinal cell differentiation.

Scenario 5: Congenital Deficiency of Intestinal Barrier Function A pediatric patient with history of recurrent infections, malabsorption, and multiple food allergy since the first months of life. Specialized evaluation reveals congenital defect in tight junction proteins of the intestinal epithelium, resulting in increased intestinal permeability of genetic origin, without macroscopic structural alterations.

Scenario 6: Persistent Immaturity of the Intestinal Epithelium A premature newborn who, even after reaching adequate corrected age, maintains characteristics of persistent intestinal immaturity with malabsorption. Investigation excludes other causes and identifies defect in the postnatal maturation process of the intestinal epithelium of genetic basis, characterizing developmental anomaly.

4. When NOT to Use This Code

It is fundamental to recognize situations where code DA90 is not appropriate, avoiding coding errors that may compromise care and medical records:

Structural Malformations: Code DA90 should not be used for intestinal atresia, congenital stenoses, intestinal duplications, or other evident anatomical malformations. These conditions have specific codes in ICD-11 and represent macroscopic structural defects, not functional anomalies or cellular differentiation disorders.

Acquired Conditions: Enteritis, necrotizing enterocolitis, short bowel syndrome post-surgical, or any intestinal pathology developed after birth should not be coded as DA90. This code is exclusive for congenital developmental anomalies, not for conditions acquired during life.

Celiac Disease: Although it causes villous atrophy, celiac disease is an acquired autoimmune condition, not a congenital anomaly of intestinal development. It has a specific code in ICD-11 and should not be confused with congenital enteropathies.

Acquired Food Intolerances: Lactose intolerance that develops in childhood or adulthood due to physiological reduction of lactase is not a congenital anomaly and should not be coded as DA90. The deficiency must clearly be of congenital origin and present from birth or the first months of life.

Intestinal Infections: Infectious gastroenteritis, even if it causes temporary damage to the intestinal mucosa in neonates, are not developmental anomalies and require codes from the chapter on infectious diseases.

Functional Obstructions: Meconium ileus, meconium plug syndrome, or other functional obstructions of the neonatal period, even if related to congenital conditions, have specific coding and should not be classified as DA90, unless there is clear documentation of underlying non-structural developmental anomaly of intestinal development.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

The first fundamental step is to confirm that this is a congenital anomaly of the small intestine. This requires:

Temporal documentation: Evidence that symptoms began in the neonatal period or first months of life, suggesting congenital origin. Detailed clinical history should document early symptom onset and its persistence.

Exclusion of acquired causes: Complete investigation to rule out infections, postnatal toxic exposures, trauma, or other acquired causes of intestinal dysfunction.

Diagnostic evaluations: May include intestinal biopsy with histological and histochemical analysis, absorptive function tests, enzymatic assays in intestinal mucosa, molecular genetic studies when indicated, and imaging studies to exclude structural malformations.

Confirmation of non-structural nature: Imaging studies (ultrasonography, contrast radiography, computed tomography or magnetic resonance imaging when indicated) should confirm the absence of gross anatomical malformations such as atresias, stenoses, or duplications.

Step 2: Verify Specifiers

After confirming the base diagnosis, it is necessary to adequately characterize the condition:

Severity: Document whether the anomaly causes mild, moderate, or severe symptoms. Consider need for nutritional support, frequency and intensity of symptoms, and impact on growth and development.

Specific type of anomaly: Identify whether it is enzymatic deficiency, defect in cell differentiation, intestinal barrier anomaly, or another specific subtype. This may require subcodes or additional documentation.

Clinical manifestations: Record predominant symptoms such as diarrhea, malabsorption, specific food intolerances, failure to thrive, or nutritional complications.

Response to management: Document whether the condition responds to dietary modifications, enzymatic support, or requires parenteral nutrition, as this reflects the functional severity of the anomaly.

Step 3: Differentiate from Other Codes

DA91: Obstruction of the small intestine The key difference is that DA91 refers to mechanical blockages of intestinal transit, whether congenital (atresia, stenosis) or acquired. In DA90, there is no mechanical obstruction, but rather dysfunction due to anomaly of cellular or functional development. If there is radiological or surgical evidence of anatomical obstruction, use DA91, not DA90.

DA92: Other acquired anatomical alterations of the small intestine This code is for anatomical alterations that develop after birth, such as post-surgical adhesions, inflammatory stenoses, or other acquired structural changes. The fundamental difference is that DA92 is for acquired conditions and DA90 for congenital anomalies. Temporality and etiology are the main differentiators.

DA93: Disorders of small intestine motility DA93 encompasses conditions where the primary problem is abnormal intestinal motility, such as chronic intestinal pseudo-obstruction or dysmotility. Although some congenital anomalies may affect motility, use DA90 when the primary defect is an anomaly of cellular or functional development, and DA93 when the problem is primarily motor, without underlying structural anomaly or cell differentiation defect.

Step 4: Required Documentation

For adequate coding with DA90, the medical record must contain:

Mandatory checklist:

Detailed clinical history with age of symptom onset
Clear description of symptoms and clinical signs
Imaging study results excluding structural malformations
Intestinal biopsy report when performed, with histological description
Results of functional tests (absorption, enzymes, permeability)
Genetic studies when available and performed
Documented exclusion of acquired or infectious causes
Assessment of growth and nutritional status
Therapeutic plan and treatment response

Adequate documentation: The documentation must clearly identify the condition as a congenital, non-structural anomaly of intestinal development, differentiating it from other pathologies. The term "non-structural anomaly of development" should be present in the diagnostic description.

6. Complete Practical Example

Clinical Case:

Sofia, a three-month-old infant, was brought to a pediatric gastroenterology consultation with a history of persistent watery diarrhea since the first month of life. The parents report that after the first few weeks with exclusive breastfeeding without problems, the introduction of formula resulted in frequent liquid stools (8-10 times per day), abdominal distension, and irritability after feeding.

Anthropometric evaluation revealed deceleration of weight gain, with weight below the 10th percentile for age, despite adequate length. Physical examination showed mild dehydration, abdominal distension without palpable masses, and absence of evident malformations.

Initial investigation included stool tests negative for infectious pathogens, negative occult blood, and electrolytes showing mild metabolic acidosis. Abdominal ultrasound demonstrated no structural malformations, obstructions, or anatomical alterations of the small intestine.

Due to persistence of symptoms and therapeutic failure with hypoallergenic formulas, upper gastrointestinal endoscopy with duodenal biopsy was performed. The endoscopic examination showed mucosa with normal appearance, without signs of macroscopic villous atrophy. However, histochemical analysis of the biopsy revealed significantly reduced enzymatic activity of lactase and sucrase-isomaltase in intestinal epithelial cells, with preserved villous architecture and absence of inflammatory infiltrate.

Subsequent genetic studies identified a mutation in the LCT gene, confirming primary congenital lactase deficiency. The child was managed with lactose-free formula, presenting complete resolution of symptoms, normalization of bowel pattern, and recovery of weight gain in the subsequent weeks.

Step-by-Step Coding:

Criteria analysis:

Early onset of symptoms (first month of life): ✓
Congenital nature confirmed (genetic mutation): ✓
Absence of structural malformation (imaging and endoscopy normal): ✓
Defect in cellular development/function (congenital enzymatic deficiency): ✓
Exclusion of acquired causes (infections ruled out): ✓

Code chosen: DA90 - Non-structural anomalies of small intestine development

Complete justification: Sofia's case clearly represents a non-structural anomaly of intestinal development. Congenital disaccharidase deficiency is a defect in differentiation or cellular function of the intestinal epithelium that does not cause macroscopic structural alterations. The genetic origin confirms the congenital nature, and the absence of anatomical malformations on imaging and endoscopy confirms the non-structural character of the anomaly.

The DA90 code is appropriate because:

The condition is congenital (present from birth, manifesting early)
It involves a defect in intestinal cellular development (primary enzymatic deficiency)
There is no anatomical structural malformation
It is not mechanical obstruction (excluding DA91)
It is not an acquired condition (excluding DA92)
The primary problem is not motility (excluding DA93)

Applicable complementary codes:

Code for malnutrition/failure to thrive, if present and significant
Code for dehydration, if documented at the time of evaluation
Code for the specific genetic defect, if the system allows detailed genetic coding

7. Related Codes and Differentiation

Within the Same Category:

DA91: Obstruction of the small intestine

When to use DA91 vs. DA90: Use DA91 when there is mechanical blockage of intestinal transit, evidenced by proximal distension to the obstruction, air-fluid levels on radiographs, or surgical/endoscopic confirmation of luminal narrowing or occlusion. Examples include intestinal atresia, congenital stenosis, adhesive bands, or volvulus. Use DA90 when there is no mechanical obstruction, but rather dysfunction due to cellular or functional anomaly.

Main difference: DA91 is anatomic/mechanical (something physically blocks the intestine), whereas DA90 is functional/cellular (intestinal cells did not develop or function adequately, without physical blockage).

DA92: Other acquired anatomical alterations of the small intestine

When to use DA92 vs. DA90: Use DA92 for structural alterations that develop after birth, such as stenosis post-necrotizing enterocolitis, post-operative adhesions, acquired diverticula, or other anatomical changes secondary to post-natal pathological processes. Use DA90 exclusively for anomalies present since birth or fetal development.

Main difference: Temporality and etiology - DA92 is acquired (developed after birth), whereas DA90 is congenital (present since fetal development).

DA93: Motility disorders of the small intestine

When to use DA93 vs. DA90: Use DA93 when the primary problem is coordination or strength of intestinal contractions, as in chronic intestinal pseudo-obstruction, gastroparesis, or primary dysmotility. Use DA90 when there is a defect in cellular development, even if it secondarily affects motility.

Main difference: DA93 is primarily motor (problem in muscle contraction or neural coordination), whereas DA90 is primarily cellular/functional development (problem in formation or differentiation of intestinal cells).

Differential Diagnoses:

Celiac Disease: May present with similar symptoms with malabsorption and villous atrophy, but is an acquired autoimmune condition, not a congenital anomaly. Distinguished by specific serology (anti-transglutaminase antibodies), age of presentation typically after gluten introduction, and reversibility with a gluten-free diet.

Cow's Milk Protein Allergy: May cause gastrointestinal symptoms in infants, but is an acquired immunological reaction, not a congenital defect of intestinal development. Distinguished by presentation after milk exposure, presence of other allergic signs, and response to protein exclusion.

Persistent Intestinal Infections: May cause prolonged diarrhea, but have acute onset, pathogen identification, and generally spontaneous resolution or resolution with antimicrobial treatment. They are neither congenital nor involve developmental defects.

8. Differences with ICD-10

In ICD-10, congenital anomalies of the intestine were coded in a less specific manner, generally under code Q43 (Other congenital malformations of the intestine), without clear differentiation between structural and non-structural anomalies.

Closest ICD-10 code: Q43.9 - Congenital malformation of the intestine, unspecified

Main changes in ICD-11:

ICD-11 introduces greater specificity by creating code DA90 specifically for non-structural anomalies, recognizing that not all congenital anomalies are visible anatomical malformations. This distinction is clinically relevant because:

Functional vs. structural differentiation: ICD-11 clearly separates anatomical defects from functional/cellular defects, allowing better diagnostic characterization.
Greater epidemiological precision: Allows more specific studies on different types of congenital intestinal anomalies.
Therapeutic guidance: The distinction facilitates management planning, as structural anomalies frequently require surgical intervention, while non-structural anomalies are generally managed clinically.

Practical impact of these changes:

For healthcare professionals, the transition to ICD-11 requires greater diagnostic precision and more detailed documentation. It is no longer appropriate to use generic codes for intestinal malformations; it is necessary to determine whether the anomaly is structural or non-structural.

For health information systems, the change allows better tracking of specific conditions, facilitating resource allocation and planning of specialized services. Epidemiological studies gain precision, allowing better understanding of the prevalence and impact of these conditions.

For patients and families, more specific coding can facilitate access to appropriate treatments and connection with support groups specific to their conditions.

9. Frequently Asked Questions

1. How is the diagnosis of non-structural anomalies of intestinal development made?

The diagnosis generally requires a multifaceted approach. It begins with a detailed clinical history, identifying early symptoms such as persistent diarrhea, malabsorption, or food intolerances from the neonatal period. Imaging studies (ultrasonography, contrast radiographs) are performed to exclude structural malformations. Confirmation frequently requires upper gastrointestinal endoscopy with intestinal biopsy, where histological, histochemical, and sometimes molecular analyses identify defects in cell differentiation, enzymatic deficiencies, or other cellular anomalies. Functional tests such as absorption studies and enzymatic assays complement the evaluation. In selected cases, genetic studies may identify specific mutations responsible for the anomaly.

2. Is treatment available in public health systems?

The availability of treatment varies according to the infrastructure of each health system, but basic interventions are generally accessible in public systems. Management includes dietary modifications (special formulas, elimination diets), enzymatic supplementation when indicated, and nutritional support. In severe cases requiring prolonged parenteral nutrition, access may be more limited and depends on the technical capacity of the service. Most patients with non-structural anomalies can be managed with nutritional and pharmacological interventions available in pediatric gastroenterology referral centers, which exist in many public health systems.

3. How long does treatment last?

The duration of treatment depends on the specific nature of the anomaly. Some congenital enzymatic deficiencies, such as lactase deficiency, require lifelong dietary management, although patients generally adapt well with appropriate diets. Other anomalies may improve with intestinal maturation during childhood, allowing gradual diet expansion. More severe conditions requiring parenteral nutrition may require prolonged support, sometimes for years, until intestinal adaptations or therapeutic interventions allow transition to enteral nutrition. Medical follow-up is generally necessary throughout childhood and, in some cases, into adulthood, even when symptoms are controlled.

4. Can this code be used in medical certificates?

Yes, the code DA90 can and should be used in medical certificates when appropriate, as it precisely identifies the patient's condition. In certificates for school, occupational (for parents/guardians), or social security purposes, appropriate coding documents the congenital and chronic nature of the condition, justifying special needs such as specific diets, absences for frequent medical appointments, or activity limitations. Accurate documentation is also important for requests for special formulas, medications, or equipment necessary for treatment. It is recommended that the certificate include not only the code but also a clear description of the condition and its functional implications.

5. Can these anomalies be detected before birth?

Most non-structural anomalies of intestinal development cannot be detected by prenatal ultrasonography, as they do not cause visible anatomical changes. Unlike structural malformations such as intestinal atresia (which may show signs such as polyhydramnios or fetal intestinal dilation), functional or cellular anomalies generally only manifest after birth, when the intestine needs to perform its digestive and absorptive functions. In families with a known history of specific genetic conditions, it may be possible to perform prenatal genetic testing to detect known mutations, but this is not routine and depends on prior knowledge of the familial mutation.

6. Is the condition hereditary? Will future siblings have the same problem?

Many non-structural anomalies of intestinal development have a genetic basis, and some follow Mendelian inheritance patterns (autosomal recessive being the most common). When the condition is caused by an identified genetic mutation, the risk of recurrence in future siblings can be calculated. For autosomal recessive conditions, the risk is 25% in each pregnancy if both parents are carriers. However, not all anomalies are monogenic; some result from complex interactions between multiple genes and environmental factors, making the risk of recurrence more difficult to predict. Genetic counseling is recommended for affected families planning future pregnancies, allowing individualized discussion of risks and options.

7. Can children with these anomalies have normal development?

With early diagnosis and appropriate management, many children with non-structural anomalies of intestinal development can achieve normal physical and neurological development. The prognosis depends on the severity of the condition, the timeliness of diagnosis, and the adequacy of treatment. Prolonged nutritional deficiencies can affect growth and development, making careful monitoring and appropriate nutritional intervention essential. Some milder conditions, such as isolated enzymatic deficiencies, have an excellent prognosis with simple dietary modifications. More severe conditions may require intensive nutritional support, but even so, many children eventually achieve transition to oral feeding and adequate development. Multidisciplinary follow-up including a gastroenterologist, nutritionist, and pediatrician is fundamental to optimize outcomes.

8. What is the difference between this condition and common food intolerances?

The fundamental difference lies in the origin and nature of the condition. Non-structural anomalies of intestinal development coded as DA90 are congenital defects present from birth, resulting from alterations in fetal development, often with a genetic basis. They manifest early (neonatal period or first months of life) and are permanent. Common food intolerances, such as lactose intolerance that develops in late childhood or adulthood, are acquired conditions resulting from the normal physiological reduction in lactase production with age. These are not developmental anomalies, do not have a pathological genetic basis, and develop gradually. The distinction is important because it determines the prognosis, management, and need for additional investigations.

Conclusion

The DA90 code from ICD-11 represents an important advance in the classification of congenital intestinal anomalies, recognizing that not all congenital conditions are evident structural malformations. Appropriate coding of these non-structural anomalies of intestinal development requires a clear understanding of their functional and cellular nature, distinguishing them from mechanical obstructions, acquired conditions, and motility disorders. With appropriate documentation and correct application of this code, healthcare professionals contribute to accurate medical records, facilitate epidemiological research, and ensure that patients receive appropriate management for their specific conditions.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-03

Non-structural anomalies of small intestine development

Compartilhar